High Note Wealth’s GSK GSK Stock Holding History

High Note Wealth’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$52	Hold	1	–	–	﹤0.01%	952
2026 Q1	$55	Hold	1	–	–	﹤0.01%	925
2025 Q4	$49	Hold	1	–	–	﹤0.01%	900
2025 Q3	$43	Sell	1 -6	-86%	-$234	﹤0.01%	859
2025 Q2	$269	Hold	7	–	–	﹤0.01%	795
2025 Q1	$271	Hold	7	–	–	﹤0.01%	781
2024 Q4	$237	Buy	+7	New	+$252	﹤0.01%	801

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

High Note Wealth's GSK Position: Q2 2026 in Review

High Note Wealth held its GSK (GSK) position steady in Q2 2026 at 1 share worth $52. The position accounts for ﹤0.01% of the portfolio, ranked #952.

High Note Wealth first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. The position peaked at $271 in Q1 2025. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

High Note Wealth held 1 share of GSK worth $52 as of Q2 2026.
High Note Wealth left its GSK share count unchanged in Q2 2026.
GSK made up ﹤0.01% of High Note Wealth's portfolio in Q2 2026, its #952 holding.
High Note Wealth first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
High Note Wealth's GSK position peaked at $271 in Q1 2025.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on High Note Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.